PPRX-1701, a nanoparticle formulation of 6′-bromoindirubin acetoxime, improves delivery and shows efficacy in preclinical GBM models
Mykola Zdioruk(Brigham and Women's Hospital), Sean Lawler(Brigham and Women's Hospital)
Cited by 13
Related Papers
Blood-brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents
|Nature Communications|2017|332
Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis
|Journal of Clinical Investigation|2019|75
A Pt(IV)-conjugated brain penetrant macrocyclic peptide shows pre-clinical efficacy in glioblastoma
|Journal of Controlled Release|2022|27
STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models
|bioRxiv (Cold Spring Harbor Laboratory)|2022|13